Literature DB >> 14744595

Antiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells.

Kyung-Hye Lee1, SoYeon Lim, Seok-Min Kang, Dae Hyeok Kim, Hong Keun Cho, Ji Hyung Chung, Hyuck Moon Kwon, kwang-Hoe Chung, Hakbae Lee, Yangsoo Jang, Ki-Chul Hwang.   

Abstract

Reactive oxygen species-mediated cellular injury is involved in the pathogenesis of many diseases, including those affecting the cardiovascular system, such as myocardial ischemia-reperfusion injury, inflammation, and atheroscleosis. Raxofelast (IRFI-016; (+/-)-5-acetoxy-2, 3-dihydro-4, 6, 7-trimethyl-2-benzofuran-acetic acid) was designed with the aim of maximizing the antioxidant potency of phenols chemically related to vitamin E. The antioxidant activity of raxofelast has been convincingly demonstrated in several in vitro studies and in various models of ischemia-reperfusion injury. In this study, the antiproliferative effects of raxofelast were investigated to determine whether transduction signals and protooncogenes are affected in H(2)O(2)-stimulated rat aortic smooth muscle cells. In a tetrazolium-based colorimetric assay, the proliferation of rat aortic smooth muscle cells was increased by 3-fold in 0.1% fetal bovine serum/Dulbecco's modified Eagle's medium (DMEM) containing 500 microM H(2)O(2), indicating that exogenous 500 microM H(2)O(2) was a growth stimulator of rat aortic smooth muscle cells. Exogenous H(2)O(2) significantly activated extracellular signal-regulated kinases (ERKs) activity within 30 min and raxofelast inhibited the ERKs activation dose dependently in 500 microM H(2)O(2)-stimulated rat aortic smooth muscle cells (IC(50): 200 microM). Raxofelast reduced the intracellular reactive oxygen species generated by exogenous H(2)O(2) in a dose-dependent manner. In 500 microM H(2)O(2)-stimulated rat aortic smooth muscle cells, raxofelast dramatically attenuated the activation of mitogen-activating protein kinase (MAPK)/ERK kinase 1, 2 (MEK1,2) and protein kinase C (PKC) without affecting Ras expression. Induction of c-myc mRNA was significantly reduced dose dependently up to 100 microM by raxofelast in concentrations. These data indicate that the antiproliferative effects of raxofelast in H(2)O(2)-stimulated rat aortic smooth muscle cells may involve the suppression of intracellular reactive oxygen species formation and the inhibition of ERKs by inactivation through PKC and MEK1,2 and down-regulation of c-myc expression, regardless of Ras activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744595     DOI: 10.1016/j.ejphar.2003.11.012

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy.

Authors:  Young Won Yoon; Tae Soo Kang; Byoung Kwon Lee; Woochul Chang; Ki-Chul Hwang; Ji-Hyuck Rhee; Pil-Ki Min; Bum-Kee Hong; Se-Joong Rim; Hyuck Moon Kwon
Journal:  Exp Mol Med       Date:  2008-08-31       Impact factor: 8.718

2.  Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cells.

Authors:  Qing-wen Chen; Lars Edvinsson; Cang-Bao Xu
Journal:  BMC Cell Biol       Date:  2009-07-03       Impact factor: 4.241

3.  The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease.

Authors:  Paul C Evans
Journal:  EPMA J       Date:  2011-02-12       Impact factor: 6.543

4.  The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway.

Authors:  Sungha Park; Soyeon Lim; Woochul Chang; Heesang Song; Sunju Lee; Byeong-Wook Song; Hye-Jung Kim; Min-Ji Cha; Eunju Choi; Yangsoo Jang; Namsik Chung; Seung Yun Cho; Ki-Chul Hwang
Journal:  Yonsei Med J       Date:  2008-08-30       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.